Junko Hashimoto

549 total citations
27 papers, 445 citations indexed

About

Junko Hashimoto is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Junko Hashimoto has authored 27 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Orthopedics and Sports Medicine, 16 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Junko Hashimoto's work include Bone health and treatments (15 papers), Bone health and osteoporosis research (14 papers) and Bone and Joint Diseases (8 papers). Junko Hashimoto is often cited by papers focused on Bone health and treatments (15 papers), Bone health and osteoporosis research (14 papers) and Bone and Joint Diseases (8 papers). Junko Hashimoto collaborates with scholars based in Japan, United States and Switzerland. Junko Hashimoto's co-authors include Kaoru Miyazaki, Yoshinobu Kariya, Takashi Ogawa, Yoshiaki Tsubota, Toshitaka Nakamura, Hiroshi Hagino, Nobuyuki Miyasaka, Masako Ito, Tetsuo Nakano and Seitaro Yoshida and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Biology of the Cell and Stem Cells.

In The Last Decade

Junko Hashimoto

26 papers receiving 433 citations

Peers

Junko Hashimoto
Zhao Chengyan United States
Courtney M. Mazur United States
Masud Khan Japan
Mary Louise Stover United States
Antje Naumann Germany
Madoka Hayashi Japan
I. M. Dahl Norway
Fangyuan Wei China
Ian D. Crabb United States
Darren A. Plumb United States
Zhao Chengyan United States
Junko Hashimoto
Citations per year, relative to Junko Hashimoto Junko Hashimoto (= 1×) peers Zhao Chengyan

Countries citing papers authored by Junko Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Junko Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Hashimoto more than expected).

Fields of papers citing papers by Junko Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junko Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Hashimoto. The network helps show where Junko Hashimoto may publish in the future.

Co-authorship network of co-authors of Junko Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Junko Hashimoto. A scholar is included among the top collaborators of Junko Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Hashimoto. Junko Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takeuchi, Yasuhiro, et al.. (2019). Effectiveness of monthly intravenous ibandronate injections in a real-world setting: Subgroup analysis of a postmarketing observational study. SHILAP Revista de lepidopterología. 5(1). 11–18. 2 indexed citations
2.
Yamaguchi, Takuya, et al.. (2019). Trial Service of Secure Computation System San-shi(TM). NTT technical review. 17(3). 16–21. 1 indexed citations
3.
4.
Hagino, Hiroshi, Masako Ito, Junko Hashimoto, et al.. (2017). Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study. Journal of Bone and Mineral Metabolism. 36(3). 336–343. 6 indexed citations
5.
Takeda, Satoshi, Sadaoki Sakai, Keisuke Tanaka, et al.. (2017). Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats. Calcified Tissue International. 101(1). 65–74. 5 indexed citations
6.
Nakano, Tetsuo, et al.. (2015). Higher response with bone mineral density increase with monthly injectable ibandronate 1 mg compared with oral risedronate in the MOVER study. Journal of Bone and Mineral Metabolism. 34(6). 678–684. 8 indexed citations
7.
Nakamura, Toshitaka, M. Ito, Junko Hashimoto, et al.. (2015). Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis. Osteoporosis International. 26(11). 2685–2693. 18 indexed citations
8.
9.
10.
Hashimoto, Junko, et al.. (2014). The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties. European Journal of Drug Metabolism and Pharmacokinetics. 41(2). 139–147. 6 indexed citations
11.
12.
Nakamura, Toshitaka, Tetsuo Nakano, Masako Ito, et al.. (2013). Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis. Calcified Tissue International. 93(2). 137–146. 49 indexed citations
13.
Felsenberg, Dieter, Oliver Bock, H. G. Borst, et al.. (2011). Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass.. PubMed. 11(1). 34–45. 17 indexed citations
14.
Ogawa, Takashi, Yoshiaki Tsubota, Junko Hashimoto, Yoshinobu Kariya, & Kaoru Miyazaki. (2007). The Short Arm of Laminin γ2 Chain of Laminin-5 (Laminin-332) Binds Syndecan-1 and Regulates Cellular Adhesion and Migration by Suppressing Phosphorylation of Integrin β4 Chain. Molecular Biology of the Cell. 18(5). 1621–1633. 71 indexed citations
15.
Runge, Martin, et al.. (2007). Effect of alfacalcidol on volumetric bone mineral density measured by pQCT in a lend ronate-treated postmenopausal women with osteopenia or osteoporosis: 1 year interim analysis of the ALFA study.. 1. 215. 1 indexed citations
16.
Hashimoto, Junko, Takashi Ogawa, Yoshiaki Tsubota, & Kaoru Miyazaki. (2005). Laminin-5 suppresses chondrogenic differentiation of murine teratocarcinoma cell line ATDC5. Experimental Cell Research. 310(2). 256–269. 10 indexed citations
17.
Hashimoto, Junko, Kazuto Sato, Megumu Higaki, et al.. (1991). The effects of antirheumatic drugs on the production of, and the responsiveness to cytokines (IL-1 and IL-6).. Ensho. 11(3). 279–286. 2 indexed citations
18.
Kamagata, Y, Nobuyuki Miyasaka, Hiroko Inoue, Junko Hashimoto, & Masato Iida. (1989). Study of cytokine production in inflamed human gingival tissues in periodontitis. Interleukin-1(IL-1.ALPHA.,.BETA.) and tumor necrosis factor(TNF.ALPHA.).. Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology). 31(3). 843–848. 7 indexed citations
19.
Miyasaka, Nobuyuki, Kazuto Sato, Junko Hashimoto, et al.. (1989). Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium. Clinical Immunology and Immunopathology. 52(2). 238–247. 45 indexed citations
20.
Kamagata, Y, Nobuyuki Miyasaka, Hiroko Inoue, Junko Hashimoto, & Masato Iida. (1989). Cytokine production in inflamed human gingival tissues - Interleukin-6.. Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology). 31(4). 1081–1087. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhao Chengyan Breakdown of academic impact, for papers by Courtney M. Mazur Breakdown of academic impact, for papers by Masud Khan Breakdown of academic impact, for papers by Mary Louise Stover Breakdown of academic impact, for papers by Antje Naumann Breakdown of academic impact, for papers by Madoka Hayashi Breakdown of academic impact, for papers by I. M. Dahl Breakdown of academic impact, for papers by Fangyuan Wei Breakdown of academic impact, for papers by Ian D. Crabb Breakdown of academic impact, for papers by Darren A. Plumb
Rankless by CCL
2026